No phaseStatus unknownAge-related condition
A randomized, double-blind, controlled clinical study of the Balingfu nutrient regimen for the treatment of menopausal or perimenopausal syndrome.
- Sponsor
- Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
- Enrollment
- 30 planned
- Conditions
- Pre-menopausal/menopausal syndrome
- Interventions
- Oral Bai Ling Fu nutritional supplement package; 3 tablets per time, 2 times daily; duration of treatment is 4 weeks for all participants; Oral placebo
- Ages
- adults
- Registry
- ChiCTR2600130674
Full record on the Chinese Clinical Trial RegistrySource: WHO ICTRP, processed August 31, 2026
Primary outcomes
- Menopausal symptom score;
History
Started
Last registry update
Registered